2014 Opportunities in the US Blood Banking Market

NEW YORK, Sept. 11, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2014 Opportunities in the US Blood Banking Market
http://www.reportlinker.com/p01622683/2014-Opportunities-in-the-US-Blood-Banking-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

2014 Opportunities in the US Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

Rationale

During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leading
suppliers of blood banking of reagentsand instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,and key suppliers.

- Test volume and sales forecasts for over 40
blood banking tests, including NAT, by market segment:

- Blood Centers
- Plasma Fractionation Facilities
- Hospitals
- Commercial/Private Laboratories
- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging blood banking tests.

- Review of automated and semi-automated
analyzers, including their operating characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging technologies,and their potential applications for the blood banking market.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Contains 460 pages and 53 tables

I. Introduction

II. Major Product Development Opportunities

A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

III. Alternative Market Penetration Strategies

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

IV. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

V. Worldwide Technology and Market Overview

A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS
- Structure and Composition
- Classification
- Origin of AIDS
- Animal Lentivirus Systems
- Virus Receptors
- HIV Infections in Humans
° Pathogenesis & Pathology
° Overview of Course of HIV Infection
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
° Clinical Findings
- Plasma Viral Load
- Pediactric AIDS
° Neurologic Disease
° Opportunistic Infections
° Protozoa
° Fungi
° Bacteria
- Viruses
- Cancer
- Immunity
- Laboratory Diagnosis
° Virus Isolation

° Serology
° Detection of Viral Nucleic Acid or Antigens
- Epidemiology
° Worldwide Spread of AIDS
° United States
° Routes of Transmission
- Prevention, Treatment, And Control
° Antiviral Drugs
° Vaccines Against HIV
- Transmission of HIV in Blood Products
- HIV Transmission in Transplant and
Artificial Insemination Recipients
- Diagnostic Tests
° Enzyme Immunoassay Interpretation
° Specificity, Sensitivity, and Predictive
Value of Enzyme Immunoassay
- Competition Assays
- Western Blot Technique
- Immuno-Fluorescence Assay (IFA)
- Radioimmunoprecipitation
- HIV-1/HIV-2 Combination Testing
- Methods of HIV-Antigen Detection
- Antigen Assays and Blood Screening
- Urine Tests
- DNA Probes
° Overview
° Quantitative Polymerase Chain Reaction
° In Situ PCR
° Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis
- Hepatitis A
- Hepatitis B
° Structure and Composition
° Replication of Hepatitis B Virus
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G

- Hepatitis Virus Infections In Humans
° Pathology
- Clinical Findings
- Laboratory Features
° Hepatitis A
° Hepatitis B
° Hepatitis C
° Hepatitis D
° Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
° Hepatitis A
° Hepatitis B
° Hepatitis C
° Hepatitis D (Delta Agent)
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
° Erythema Infectiosum Slapped (cheek)
° Adult Polyarthropathy

° Transient Aplastic Crisis
° Transient Pancytopenia
° Red Cell Aplasia in the Immunocompromised
° Perinatal Infections
- Diagnosis
- Treatment
g. Creutzfeldt-Jakob's Disease
- Background
- Transmission
- Diagnostic Tests
- Major Commercial and Academic Players
° Bayer
° Disease Sciences/BioTec Global
° Imperial College School of Medicine
° Ortho-Clinical Diagnostics
° Pall
° ProMetic Life Sciences
° Proteome Sciences/Idexx
° Q-One Biotech
° Serono
° U.S. Agricultural Research Service
- Drugs
- Vaccines
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Automated
and Semiautomated Analyzers Manufactured by:
- Abbott
- Beckman Coulter/Danaher
- Bio-Rad
- BioMerieux
- Gen-Probe
- Grifols
- Immucor
- Nanosphere

- Ortho-Clinical Diagnostics
- Roche
- Sarstedt
- Siemens
- Tecan
C. Major in Vitro Diagnostic Technologies
And Their Potential Applications
1. Molecular Diagnostics
a. Overview
b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing

VI. U.S.A.

A. Executive Summary
B. Business Environment
1. Overview
2. Health Care Expenditures
3 Cost Consciousness
4. Industry Consolidation
5. Managed Care
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illnesses
b. Disease Incidence
c. Susceptibility to Latrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
C. Market Structure
D. Market Size, Growth and Major Suppliers'
Sales and Market Shares

VII. Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio/Innogenetics
- Hologic/Gen-Probe
- Grifols
- Immucor
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Orchid CellMark
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens
- Tecan

VIII. Appendix: Assumed Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or Marketing
HLA Typing Tests
Major Companies Developing or Marketing
AIDS Tests
Major Companies Developing or Marketing
Hepatitis Tests
Major Companies Developing or Marketing
CMV Tests
Major Companies Developing or Marketing
Syphilis Tests
Major Companies Developing or Marketing
Blood Bank Analyzers
Executive Summary Table: U.S.A., Total Blood Bank
Test Volume and Reagent Sales Forecast
by Test Category
U.S.A., Estimated Number of Inpatient and
Ambulatory Surgeries
U.S.A., Facilities Performing Blood
Bank Tests by Market Segment
U.S.A., Hospital Laboratories Performing
Blood Bank Tests by Bed Size
U.S.A., Commercial/Private Laboratories
Performing Blood Bank Tests
by Annual Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood
And Plasma by Market Forecast Segment
U.S.A., Whole Blood and Plasma Collections
By Market Forecast Segment
U.S.A., All Market Segments Blood Typing
and Grouping Test Volume by Market Forecast
Segment
U.S.A., All Market Segments Blood Typing

And Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood
Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Test Volume Forecast
U.S.A., Commercial/Private Laboratories
Blood Typing and Grouping Test Volume Forecast
U.S.A., Plasma Fractionation Centers Blood
Typing and Grouping Test Volume Forecast
U.S.A., Military Blood Banks Blood Typing
and Grouping Test Volume Forecast
U.S.A., All Market Segments Infectious
Disease Screening Test Volume Forecast
By Market Segment
U.S.A., All Market Segments Infectious
Disease Screening Test Volume Forecast
U.S.A., Community and Regional Centers
Infectious Disease Screening Test Volume Forecast
U.S.A., Plasma Fractionation Centers
Infectious Disease Screening Test Volume Forecast
U.S.A., Hospital Blood Banks
Infectious Disease Screening Test Volume Forecast
U.S.A., Military Blood Banks Infectious
Disease Screening Test Volume Forecast
U.S.A., All Market Segments Blood Typing
And Grouping Reagent Market Forecast
by Market Segment

U.S.A., All Market Segments Blood Typing
And Grouping Reagent Market Forecast
by Market Segment
U.S.A., Hospital Blood Banks Blood Typing
And Grouping Reagent Market Forecast
by Major Test
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Commercial/Private Laboratories
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Plasma Fractionation Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Military Blood Banks Blood Typing
And Grouping Reagent Market Forecast by Major Test
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market by Market Forecast
Segment
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market by Market Forecast
Segment
U.S.A., Community and Regional Centers
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Plasma Fractionation Centers
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Hospital Blood Banks
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Military Blood Banks Infectious
Disease Screening Reagent Market Forecast
By Test
U.S.A., Major Suppliers of Blood Typing
And Grouping Reagents Estimated Sales
And Market Shares
U.S.A., HIV/HTLV Blood Screening Market,
Reagent Sales by Major Supplier
U.S.A., Hepatitis Blood Screening Market,
Reagents Sales by Major Supplier
U.S.A., Hepatitis C Blood Screening Market,
Reagent Sales By Major Supplier
U.S.A., HIV/Hepatitis C NAT Market, Reagent
Sales By Major Supplier
U.S.A., West Nile Virus NAT Market,
Reagent Sales by Major Supplier
U.S.A., CMV Blood Screening Market,
Reagent Sales by Major Supplier
U.S.A., Syphilis Blood Screening Market,
Reagent Sales by Major Supplier

To order this report: 2014 Opportunities in the US Blood Banking Market
http://www.reportlinker.com/p01622683/2014-Opportunities-in-the-US-Blood-Banking-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker